BioSIM 抗人 CD85k/LILRB4 抗体，生物类似

BioSIM 抗人 CD85k/LILRB4 抗体 (IO-202 生物类似药)

产品概述

BioSIM anti-Human CD85k/LILRB4 Antibody (IO-202 Biosimilar) 是一款高品质科研级二抗，专为研究人类免疫检查点分子CD85k/LILRB4而设计。作为IO-202的生物类似药，该抗体采用先进的重组技术在无动物成分的设施中生产，确保了产品的一致性和可靠性。

产品特点

• 高特异性：针对人CD85k/LILRB4分子，具有优异的靶点识别能力
• 无动物成分：在无动物成分的设施中生产，降低批次间差异
• 高纯度：经过多步骤纯化工艺，包括Protein A/G色谱，确保低背景信号
• 科研级品质：专为研究应用设计，满足严格的科研标准

研究领域与应用

该抗体适用于多种研究领域，特别是在以下方向具有重要价值：

• 白血病研究：探索CD85k/LILRB4在白血病发生发展中的作用机制
• 晚期实体瘤研究：研究肿瘤微环境中免疫检查点的调控机制
• 免疫调节研究：分析免疫细胞相互作用和信号传导通路

应用方法

BioSIM 抗人 CD85k/LILRB4 抗体兼容多种实验方法，包括：

• ELISA：用于定量分析CD85k/LILRB4表达水平
• FACS：流式细胞术分析细胞表面标记物表达
• 功能性检测：评估抗体对细胞功能的调节作用
• 体内研究：动物模型中的免疫机制探索

技术规格

储存条件

为确保抗体活性和稳定性，请遵循以下储存建议：

• 避免反复冻融：多次冻融可能导致抗体活性下降
• 短期保存（1-2周）：4°C冷藏
• 中期保存（最长12个月）：-20°C冷冻
• 长期保存：-80°C超低温保存

产品信息

BioSIM 抗人 CD85k/LILRB4 抗体采用先进的体外无蛋白细胞培养技术生产，确保了产品的高纯度和低批次间差异。多步骤纯化工艺，包括Protein A/G色谱，进一步提高了抗体的特异性和稳定性，使其成为免疫学研究、肿瘤生物学研究和药物开发领域的理想工具。

注意：以上信息可能随着产品优化升级等因素产生变动，具体信息请咨询亚科因公司。

BioSIM Anti-Human CD85k/LILRB4 Antibody (IO-202 Biosimilar)

Product Overview

BioSIM anti-Human CD85k/LILRB4 Antibody (IO-202 Biosimilar) is a high-quality research-grade secondary antibody specifically designed for studying the human immune checkpoint molecule CD85k/LILRB4. As a biosimilar of IO-202, this antibody is produced using advanced recombinant technology in animal component-free facilities, ensuring product consistency and reliability.

Product Features

• High Specificity: Targets human CD85k/LILRB4 molecules with excellent target recognition capability
• Animal Component-Free: Produced in animal component-free facilities to reduce inter-batch variation
• High Purity: Purified through multiple-step processes including Protein A/G chromatography to ensure low background signals
• Research-Grade Quality: Designed specifically for research applications, meeting rigorous scientific standards

Research Areas and Applications

This antibody is suitable for various research fields, with particular value in the following areas:

• Leukemia Research: Exploring the mechanism of CD85k/LILRB4 in the development and progression of leukemia
• Advanced Solid Tumor Research: Investigating regulatory mechanisms of immune checkpoints in the tumor microenvironment
• Immunomodulation Research: Analyzing immune cell interactions and signaling pathways

Application Methods

BioSIM Anti-Human CD85k/LILRB4 Antibody is compatible with various experimental methods, including:

• ELISA: Used for quantitative analysis of CD85k/LILRB4 expression levels
• FACS: Flow cytometry analysis of cell surface marker expression
• Functional Assays: Evaluating the regulatory effects of antibodies on cell functions
• In Vivo Studies: Exploring immune mechanisms in animal models

Technical Specifications

Storage Conditions

To ensure antibody activity and stability, please follow the storage recommendations below:

• Avoid repeated freeze-thaw cycles: Multiple freeze-thaw cycles may lead to decreased antibody activity
• Short-term storage (1-2 weeks): Store at 4°C
• Medium-term storage (up to 12 months): Store at -20°C
• Long-term storage: Store at -80°C

Product Information

BioSIM Anti-Human CD85k/LILRB4 Antibody is produced using advanced animal-free protein-free cell culture technology, ensuring high product purity and low inter-batch variation. Multiple-step purification processes, including Protein A/G chromatography, further enhance antibody specificity and stability, making it an ideal tool for immunology research, tumor biology research, and drug development.

Note: The above information may be subject to changes due to product optimization and upgrades. Please consult Yacoin Corporation for specific information.